Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

hormonal · Mechanism Report

Can low albumin alter the relationship between total and unbound progesterone?

Low albumin may alter the relationship between total and unbound progesterone, but the clinical effect is not quantitatively defined.

PlausibleNovember 18, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Progesterone circulates partly bound to albumin and corticosteroid-binding globulin, so low albumin can alter the relationship between total and unbound hormone.

laying out figure…
0 of 1 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Progesterone circulates unbound and reversibly bound to albumin and corticosteroid-binding globulin. Low albumin may change its distribution, but the direction and magnitude of the effect cannot be determined from albumin alone.

Verified conclusion

Progesterone is not measured in isolation: circulating concentrations reflect reversible distribution among unbound hormone, albumin-bound hormone, and CBG-bound hormone. This makes binding-protein context relevant when interpreting total progesterone, especially in illness or other states affecting serum proteins.

Clinical and binding evidence

  • Human binding studies support progesterone association with both albumin and corticosteroid-binding globulin (CBG/transcortin).
  • Albumin generally carries the largest share of circulating progesterone because of its high plasma concentration, despite having much lower affinity than CBG. A compiled distribution estimate placed progesterone at 79.3% albumin-bound and 17.7% CBG-bound; equilibrium-dialysis observations similarly found approximately 15–20% CBG-associated progesterone.
  • These proportions are not fixed. Progesterone, albumin, and CBG concentrations vary by physiological state; pregnancy, for example, increases CBG and can increase its contribution to progesterone transport.

Mechanistic interpretation

  • CBG is the higher-affinity carrier, whereas albumin is a lower-affinity, high-capacity reservoir. Albumin’s abundance may buffer progesterone distribution across bound and unbound pools.
  • Because albumin carries much of progesterone under typical conditions, low albumin can plausibly alter the relationship between total progesterone and unbound progesterone. Thus, the same total concentration may not necessarily imply the same unbound concentration when albumin is reduced.
  • The magnitude and even direction of this effect cannot be inferred from albumin alone: CBG concentration, hormone concentration, binding affinities, physiological state, and potentially fatty-acid effects on albumin binding also matter.

Clinical implications

  • In hypoalbuminemia, total progesterone should be interpreted cautiously and cannot independently establish biologically available/unbound progesterone.
  • Direct clinical studies simultaneously measuring albumin, CBG, total progesterone, and reference-method free progesterone in hypoalbuminemic individuals are unavailable; therefore, no validated correction factor can be specified.

Bottom line

  • Progesterone is substantially albumin-bound and partly CBG-bound; low albumin is a credible modifier of total-to-unbound progesterone relationships, but its clinical effect is not quantitatively defined.

References

  1. Temperature-responsive release of cortisol from its binding ... — research-information.bris.ac.uk ↗
  2. TRANSCORTIN: A CORTICOSTEROID-BINDING — content-assets.jci.org ↗
  3. Plasma steroid-binding proteins: primary gatekeepers of ... - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  4. Progestogens Used in Postmenopausal Hormone Therapy ... — pmc.ncbi.nlm.nih.gov ↗
  5. The Free Hormone Hypothesis: When, Why, and How to Measure the Free Hormone Levels to Assess Vitamin D, Thyroid, Sex Hormone, and Cortisol Status — onlinelibrary.wiley.com ↗
  6. Isolation, characterization and radioimmunoassay of corticosteroid-binding globulin (CBG) in human serum - clinical significance and comparison to thyroxine-binding globulin (TBG). — epub.ub.uni-muenchen.de ↗
  7. The Free Hormone Hypothesis: When, Why, and How to Measure the Free — pmc.ncbi.nlm.nih.gov ↗
  8. Gut, 1982, 23, 276-279 — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan higher SHBG contribute to androgen deficiency in men?→Plausible4 sourcesDoes FSH rise as ovarian function declines during the menopausal transition?→